Medical research

Approach to deadly sepsis infections continues to vary

Treatment practices for patients hospitalised with the potentially fatal infection known as "sepsis" will continue to vary because of individual differences between hospitals and countries, according to University of Adelaide ...

Medical research

New septic shock biomarker test could boost better interventions

Septic shock is a severe systemic infection and major cause of death for the old and young alike. Unfortunately, researchers say testing new drug regimens to stop the infection is confounded because clinical trials include ...

Diseases, Conditions, Syndromes

ISICEM: Protocol-based tx doesn't up survival in sepsis

(HealthDay)—For patients presenting to the emergency department with sepsis and severe shock, treatment according to a protocol of early goal-directed therapy (EGDT) does not improve survival, according to a study published ...

Cardiology

ISICEM: Septic shock death equal with high, low BP target

(HealthDay)—For patients with septic shock undergoing resuscitation, 28- and 90-day mortality is not significantly different with high- or low-target arterial pressure. This research was published online March 18 in the ...

Medical research

CALS researchers developing novel treatment for septic shock

(Medical Xpress)—By the time doctors diagnose septic shock, patients often are on a knife's edge. At that point, for every hour that treatment is delayed, a person's risk of death rises an alarming six percent.

Medical research

In surprise finding, blood clots absorb bacterial toxin

Blood clots play an unexpected role in protecting the body from the deadly effects of bacteria by absorbing bacterial toxins, researchers at the University of California, Davis, have found. The research was published Dec. ...

Medical research

Research identifies potential new treatment for sepsis

Sepsis is the leading cause of in-hospital death and there is no specific treatment for it. Now, research led by Dr. Qingping Feng of Western University (London, Canada) suggests a protein called recombinant human annexin ...

page 8 from 14